SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-025353
Filing Date
2008-05-01
Accepted
2008-05-01 09:16:29
Documents
2
Period of Report
2008-04-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v112160_8k.htm 8-K 31513
2 v112160_ex99-1.htm EX-99.1 14647
  Complete submission text file 0001144204-08-025353.txt   47686
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 08792317
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1